Opposition. Novartis shall, and shall cause its Affiliates to, promptly after the Effective Date withdraw its opposition proceeding against Kreutzer-Limmer EP1144623.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)